Level Biotechnology (3118) — Free Cash Flow Generation Index
Level Biotechnology (3118) has a Free Cash Flow Generation Index of 0.62x as of September 2025. Free cash flow of NT$7.37 Million represents 1% of operating cash flow (NT$11.81 Million). Explore Level Biotechnology capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Level Biotechnology Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Level Biotechnology across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Level Biotechnology generate cash.
Annual Free Cash Flow Generation for Level Biotechnology (2017–2024)
Year-by-year Free Cash Flow Generation Index for Level Biotechnology. Check 3118 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.49x | NT$-159.58 Million | NT$64.10 Million | NT$223.68 Million | ▼ -379.5% |
| 2023 | 0.89x | NT$62.54 Million | NT$70.21 Million | NT$7.67 Million | ▼ -0.6% |
| 2022 | 0.90x | NT$58.33 Million | NT$65.07 Million | NT$6.74 Million | ▼ -4.8% |
| 2021 | 0.94x | NT$146.79 Million | NT$155.95 Million | NT$9.15 Million | ▼ -2.9% |
| 2020 | 0.97x | NT$80.69 Million | NT$83.23 Million | NT$2.54 Million | ▼ -0.8% |
| 2019 | 0.98x | NT$106.60 Million | NT$109.02 Million | NT$2.43 Million | ▲ +7.9% |
| 2018 | 0.91x | NT$24.26 Million | NT$26.77 Million | NT$2.51 Million | ▲ +3.3% |
| 2017 | 0.88x | NT$62.55 Million | NT$71.29 Million | NT$10.83 Million | — |